Invex Therapeutics (Australia) Widgets and Gadgets
| IXC Stock | 0.07 0.01 7.46% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- IXC Invex Therapeutics
- Latest Invex Therapeutics Restructures Amid Clinical Trial Challenges - TipRanks
- IXC 0.07 0.005
- Low 0.072
- High 0.072
- Alpha 0.03
- Beta 0.52
- Return On Equity -0.12
- Return On Asset -0.0922
- Profit Margin (1.35) %
- Operating Margin 0.29 %
- Current Valuation (613.99 K)
- Shares Outstanding 75.15 M
- Shares Owned By Insiders 67.72 %
- Price To Book 0.95 X
- Price To Sales 4.46 X
- Revenue 1.21 M
- Gross Profit 459.08 K
- EBITDA (720.44 K)
- Net Income (1.64 M)
- Total Debt 431.63 K
- Book Value Per Share 0.08 X
- Cash Flow From Operations (2.44 M)
- Earnings Per Share (0.02) X
- Beta 0.41
- Market Capitalization 5.41 M
- Total Asset 6.12 M
- Retained Earnings (19.22 M)
- Working Capital 5.69 M
- Net Asset 6.12 M
- Daily Balance Of Power 9.2 T
- Rate Of Daily Change 1.07
- Day Median Price 0.072
- Day Typical Price 0.072
- Price Action Indicator 0.0025
- Period Momentum Indicator 0.005
- Relative Strength Index 18.67
Market Snapshot Widget Example
DAX Index Germany | 20,399 0.34 | |
Taiwan Weighted Taiwan | 22,904 0.96 | |
PSI 20 Stock Portugal | 6,352 0.14 | |
CROBEX Croatia | 3,173 0.52 | |
Budapest SE Hungary | 80,531 0.24 | |
IDX 30 Jakarta Indonesia | 457.10 0.07 | |
ISEQ 20 Price Ireland | 1,642 0.39 | |
NYSE Comp USA | 19,891 0.05 | |
Tel Aviv 35 Israel | 2,336 0.69 | |
Coreshares Index Tracker South Afric | 1,087 1.18 | |
IPC MEXICO Mexico | 51,296 0.16 | |
KL Technology Malaysia | 62.40 0.50 | |
IBEX 35 Index Spain | 11,789 1.47 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,627 0.04 | |
SPASX Dividend Opportunities Australia | 1,696 0.38 | |
HNX 30 Vietnam | 485.48 0.81 | |
Bucharest BET-NG Romania | 1,215 1.77 | |
AMS Small Cap Netherlands | 1,251 0.03 | |
Oslo Exchange Mutual Norway | 1,404 0.08 | |
BEL Small Belgium | 8,029 0.04 | |
Basic Materials Brazil | 6,022 0.38 | |
Swiss Leader Price Switzerland | 1,936 0.39 | |
Fondo Mutuo ETF Chile | 1,395 0.20 | |
Athens General Comp Greece | 1,458 0.08 | |
Stock Exchange Of Thailand | 1,443 0.31 | |
PX Prague Stock Czech Repub | 1,722 0.46 | |
THE PHILIPPINE STOCK Philippines | 6,643 1.22 | |
WIG 30 Poland | 2,924 0.72 | |
BIST Electricity Turkey | 507.81 0.56 |
Investing Ideas
In addition to having Invex Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Invex Therapeutics
Compare Invex Therapeutics To Peers
Additional Tools for Invex Stock Analysis
When running Invex Therapeutics' price analysis, check to measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.